Biology of Blood and Marrow Transplantation
Volume 12, Issue 1 , Pages 48-60 , January 2006

Cytokine Gene Expression in Peripheral Blood Mononuclear Cells and Alloreactivity in Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning

  • Søren L. Petersen

      Affiliations

    • The Lymphocyte Research Laboratory, Department of Hematology, Rigshospitalet, Copenhagen, Denmark
    • Corresponding Author InformationCorrespondence and reprint requests: Søren L. Petersen, MD, The Lymphocyte Research Laboratory, Department of Hematology L 4041, Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
    • ,
  • Hans O. Madsen

      Affiliations

    • The Tissue Typing Laboratory, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Lars P. Ryder

      Affiliations

    • The Tissue Typing Laboratory, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Arne Svejgaard

      Affiliations

    • The Tissue Typing Laboratory, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Ebbe Dickmeiss

      Affiliations

    • The Blood Bank, Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
    • ,
  • Lars L. Vindeløv

      Affiliations

    • The Lymphocyte Research Laboratory, Department of Hematology, Rigshospitalet, Copenhagen, Denmark

Received 21 June 2005 ,Accepted 6 September 2005.

References 

  1. Schetelig J , Kroger N , Held TK , et al.   Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease . Haematologica . 2002;87:299–305
  2. Baron F , Maris MB , Sandmaier BM , et al.   Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning . J Clin Oncol . 2005;23:1993–2003
  3. Teshima T , Ordemann R , Reddy P , et al.   Acute graft-versus-host disease does not require alloantigen expression on host epithelium . Nat Med . 2002;8:575–581
  4. Reddy P , Ferrara JL . Immunobiology of acute graft-versus-host disease . Blood Rev . 2003;17:187–194
  5. Hara M , Kingsley CI , Niimi M , et al.   IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo . J Immunol . 2001;166:3789–3796
  6. Chen ZM , O’Shaughnessy MJ , Gramaglia I , et al.   IL-10 and TGF-beta induce alloreactive CD4+ . Blood . 2003;101:5076–5083
  7. Wang XN , Lange C , Schulz U , et al.   Interleukin-10 modulation of alloreactivity and graft-versus-host reactions . Transplantation . 2002;74:772–778
  8. Dickinson AM , Middleton PG , Rocha V , Gluckman E , Holler E . Genetic polymorphisms predicting the outcome of bone marrow transplants . Br J Haematol . 2004;127:479–490
  9. Mullighan CG , Bardy PG . Advances in the genomics of allogeneic haemopoietic stem cell transplantation . Drug Dev Res . 2004;62:273–292
  10. Kallianpur AR . Genomic screening and complications of hematopoietic stem cell transplantation (has the time come?) . Bone Marrow Transplant . 2005;35:1–16
  11. Jordan WJ , Brookes PA , Szydlo RM , Goldman JM , Lechler RI , Ritter MA . IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation . Blood . 2004;103:717–724
  12. Tanaka J , Imamura M , Kasai M , et al.   Cytokine gene expression in the mixed lymphocyte culture in allogenic bone marrow transplants as a predictive method for transplantation-related complications . Br J Haematol . 1994;87:415–418
  13. Tanaka J , Imamura M , Kasai M , Sakurada K . Transplantation-related complications predicted by cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants . Leuk Lymphoma . 1995;19:27–32
  14. Remberger M , Ringden O . Serum levels of cytokines after bone marrow transplantation (increased IL-8 levels during severe veno-occlusive disease of the liver) . Eur J Haematol . 1997;59:254–262
  15. Fujimori Y , Takatsuka H , Takemoto Y , et al.   Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation . Br J Haematol . 2000;109:652–657
  16. Abdallah AN , Boiron JM , Attia Y , Cassaigne A , Reiffers J , Iron A . Plasma cytokines in graft vs host disease and complications following bone marrow transplantation . Hematol Cell Ther . 1997;39:27–32
  17. Scholl S , Sayer HG , Mugge LO , et al.   Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation . J Cancer Res Clin Oncol . 2004;130:704–710
  18. Visentainer JE , Lieber SR , Persoli LB , et al.   Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation . Exp Hematol . 2003;31:1044–1050
  19. Liem LM , van Houwelingen HC , Goulmy E . Serum cytokine levels after HLA-identical bone marrow transplantation . Transplantation . 1998;66:863–871
  20. Remberger M , Jaksch M , Uzunel M , Mattsson J . Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation . Eur J Haematol . 2003;70:384–391
  21. Takatsuka H , Takemoto Y , Okamoto T , et al.   Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation . Bone Marrow Transplant . 1999;24:1005–1007
  22. Ju X , Wang J , Xu B , Cao Y , Lu S . Roles of interleukin-10 in acute graft-versus-host disease and graft rejection . Chin Med J (Engl) . 2003;116:534–537
  23. Chik KW , Li K , Pong H , Shing MM , Li CK , Yuen PM . Elevated serum interleukin-15 level in acute graft-versus-host disease after hematopoietic cell transplantation . J Pediatr Hematol Oncol . 2003;25:960–964
  24. Jaksch M , Remberger M , Mattsson J . Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation . Transplantation . 2004;77:195–200
  25. Das H , Imoto S , Murayama T , et al.   Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusion . Bone Marrow Transplant . 2001;27:373–380
  26. Carayol G , Bourhis JH , Guillard M , et al.   Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation (relationship with the occurrence of acute graft-versus-host disease) . Transplantation . 1997;63:1307–1313
  27. Tanaka J , Imamura M , Kasai M , et al.   Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation . Br J Haematol . 1993;85:558–565
  28. Tanaka J , Imamura M , Kasai M , et al.   Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation (an indicator of immunological abnormality due to chronic graft-versus-host disease) . Bone Marrow Transplant . 1994;14:695–701
  29. Tanaka J , Imamura M , Kasai M , et al.   The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease . Bone Marrow Transplant . 1997;19:571–576
  30. Jaksch M , Uzunel M , Martinez CG , Remberger M , Mattsson J . Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation . Bone Marrow Transplant . 2003;31:183–190
  31. Ju XP , Xu B , Xiao ZP , et al.   Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation . Bone Marrow Transplant . 2005;35:1179–1186
  32. Bogunia-Kubik K , Mlynarczewska A , Wysoczanska B , Lange A . Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation . Haematologica . 2005;90:425–426
  33. Mlynarczewska A , Wysoczanska B , Karabon L , Bogunia-Kubik K , Lange A . Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of a GVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation . Bone Marrow Transplant . 2004;34:339–344
  34. Takabayashi M , Kanamori H , Takasaki H , et al.   A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease . Exp Hematol . 2005;33:251–257
  35. Guo H , Qiao Z , Zhu L , et al.   Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation . Am J Hematol . 2004;75:78–83
  36. McSweeney PA , Niederwieser D , Shizuru JA , et al.   Hematopoietic cell transplantation in older patients with hematologic malignancies (replacing high-dose cytotoxic therapy with graft-versus-tumor effects) . Blood . 2001;97:3390–3400
  37. Petersen SL , Madsen HO , Ryder LP , et al.   Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting (results, complications and admission requirements in a single institution) . Br J Haematol . 2004;125:225–231
  38. Petersen SL , Madsen HO , Ryder LP , et al.   Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8 T-cell count on day +14 as a predictor of acute graft-versus-host disease . Biol Blood Marrow Transplant . 2004;10:337–346
  39. Sullivan KM . Graft-vs-host disease . In:  Thomas ED ,  Blume KG ,  Forman SJ editor. Hematopoietic Cell Transplantation . Malden, MA: Blackwell Science; 1999;p. 518–525
  40. Petersen SL , Sidorov IA , Russell CA , Dickmeiss E , Vindelov LL . Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation . Transplantation . 2005;80:573–581
  41. Russell CA , Vindelov LL . Optimization and comparison of the MTT assay and the 3H-TdR assay for the detection of IL-2 in helper T cell precursor assays . J Immunol Methods . 1998;217:165–175
  42. Petersen SL , Russell CA , Bendtzen K , Vindelov LL . Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture . Immunol Lett . 2002;84:29–39
  43. Powell MJ , Thompson SA , Tone Y , Waldmann H , Tone M . Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region . J Immunol . 2000;165:292–296
  44. Annes JP , Chen Y , Munger JS , Rifkin DB . Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1 . J Cell Biol . 2004;165:723–734
  45. Moore KW , de Waal MR , Coffman RL , O’Garra A . Interleukin-10 and the interleukin-10 receptor . Annu Rev Immunol . 2001;19:683–765
  46. Khatri VP , Caligiuri MA . A review of the association between interleukin-10 and human B-cell malignancies . Cancer Immunol Immunother . 1998;46:239–244
  47. Korholz D , Kunst D , Hempel L , et al.   Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation . Bone Marrow Transplant . 1997;19:691–695
  48. Fujimori Y , Yoshimoto T , Matsui K , et al.   Increased expression of interleukin-18 receptor on T lymphocytes in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation . J Interferon Cytokine Res . 2002;22:751–754
  49. Bacchetta R , Bigler M , Touraine JL , et al.   High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells . J Exp Med . 1994;179:493–502
  50. Russell CA , Petersen SL , Heilmann C , Madsen HO , Vindelov LL . Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay . J Immunol Methods . 2001;251:109–121
  51. Hempel L , Korholz D , Nussbaum P , Bonig H , Burdach S , Zintl F . High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation . Bone Marrow Transplant . 1997;20:365–368
  52. Baker KS , Roncarolo MG , Peters C , Bigler M , DeFor T , Blazar BR . High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths . Bone Marrow Transplant . 1999;23:1123–1129
  53. Holler E , Roncarolo MG , Hintermeier-Knabe R , et al.   Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation . Bone Marrow Transplant . 2000;25:237–241
  54. Middleton PG , Taylor PR , Jackson G , Proctor SJ , Dickinson AM . Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants . Blood . 1998;92:3943–3948
  55. Cavet J , Middleton PG , Segall M , Noreen H , Davies SM , Dickinson AM . Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants . Blood . 1999;94:3941–3946
  56. Cavet J , Dickinson AM , Norden J , Taylor PR , Jackson GH , Middleton PG . Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation . Blood . 2001;98:1594–1600
  57. Socie G , Loiseau P , Tamouza R , et al.   Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation . Transplantation . 2001;72:699–706
  58. Lin MT , Storer B , Martin PJ , et al.   Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation . N Engl J Med . 2003;349:2201–2210

PII: S1083-8791(05)00628-2

doi: 10.1016/j.bbmt.2005.09.002

Biology of Blood and Marrow Transplantation
Volume 12, Issue 1 , Pages 48-60 , January 2006

Article Tools

* Image Usage & Resolution